Hybrids as NO Donors.
NO donor
cinnamic acid
hybrids
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
10 Sep 2021
10 Sep 2021
Historique:
received:
29
07
2021
revised:
08
09
2021
accepted:
08
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
25
2
2023
Statut:
epublish
Résumé
Cinnamic acid and its derivatives have been studied for a variety of biological properties, including anti-inflammatory, antioxidant, anticancer, antihypertensive, and antibacterial. Many hybrids of cinnamic derivatives with other bioactive molecules have been synthesized and evaluated as nitric oxide (NO) donors. Since NO plays a significant role in various biological processes, including vasodilation, inflammation, and neurotransmission, NO donor groups are incorporated into the structures of already-known bioactive molecules to enhance their biological properties. In this review, we present cinnamic hybrids with NO-donating ability useful in the treatment of several diseases.
Identifiants
pubmed: 34575950
pii: ijms22189788
doi: 10.3390/ijms22189788
pmc: PMC8469192
pii:
doi:
Substances chimiques
Cinnamates
0
cinnamic acid
140-10-3
Nitric Oxide
31C4KY9ESH
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Br J Pharmacol. 2007 Jun;151(3):305-21
pubmed: 17401442
Phytomedicine. 2015 Feb 15;22(2):297-300
pubmed: 25765836
Angew Chem Int Ed Engl. 2013 Sep 2;52(36):9442-62
pubmed: 23963798
Int J Cancer. 2003 Dec 10;107(5):729-38
pubmed: 14566822
Bioorg Med Chem Lett. 2012 Oct 1;22(19):6085-8
pubmed: 22954735
J Appl Toxicol. 2001 Nov-Dec;21(6):527-31
pubmed: 11746202
Gut. 1995 Aug;37(2):247-55
pubmed: 7557576
Nutr Cancer. 2017 May-Jun;69(4):521-533
pubmed: 28362118
Expert Opin Drug Discov. 2017 Sep;12(9):941-953
pubmed: 28664751
Bioorg Med Chem. 2007 Sep 1;15(17):5819-27
pubmed: 17604175
J Lipid Res. 2009 Apr;50 Suppl:S40-5
pubmed: 18987389
Bioorg Med Chem. 2017 Aug 15;25(16):4407-4413
pubmed: 28651914
Neurochem Int. 1992 Oct;21(3):381-96
pubmed: 1303164
Curr Vasc Pharmacol. 2013 Nov;11(6):906-19
pubmed: 24168441
J Immunol. 2000 Aug 1;165(3):1582-7
pubmed: 10903767
Expert Opin Ther Pat. 2012 Feb;22(2):155-68
pubmed: 22329571
Nat Immunol. 2001 Oct;2(10):907-16
pubmed: 11577346
Curr Med Chem. 2007;14(17):1829-52
pubmed: 17627520
J Med Chem. 2005 Oct 20;48(21):6523-43
pubmed: 16220969
BMC Med. 2013 May 01;11:117
pubmed: 23635324
Eur J Med Chem. 2017 Jul 28;135:382-391
pubmed: 28460312
Molecules. 2019 Dec 19;25(1):
pubmed: 31861583
J Med Chem. 2012 May 10;55(9):4309-21
pubmed: 22512543
Expert Opin Ther Targets. 2007 Feb;11(2):161-79
pubmed: 17227232
Oxid Med Cell Longev. 2016;2016:5276130
pubmed: 27803762
Br J Pharmacol. 2002 Mar;135(5):1079-95
pubmed: 11877313
Clin Chim Acta. 2019 Sep;496:35-44
pubmed: 31229566
Molecules. 2014 Jan 27;19(2):1459-80
pubmed: 24473208
Mini Rev Med Chem. 2012 Jul;12(8):749-67
pubmed: 22512578
J Int Med Res. 2020 Feb;48(2):300060520905985
pubmed: 32090657
FASEB J. 1998 Sep;12(12):1063-73
pubmed: 9737710
Molecules. 2014 Nov 25;19(12):19292-349
pubmed: 25429559
Mini Rev Med Chem. 2001 May;1(1):57-70
pubmed: 12369991
Eur J Med Chem. 2019 Apr 15;168:515-526
pubmed: 30851694
J Appl Toxicol. 1984 Dec;4(6):283-92
pubmed: 6394637
Drugs. 1992 Oct;44(4):625-55
pubmed: 1281076
Osteoarthritis Cartilage. 1999 Jul;7(4):367-70
pubmed: 10419769
Bioorg Chem. 2019 Aug;89:103000
pubmed: 31132604
Curr Med Chem. 2011;18(11):1672-703
pubmed: 21434850
Biochem Pharmacol. 2006 Nov 30;72(11):1605-21
pubmed: 16889756
Cardiovasc J Afr. 2009 Sep-Oct;20(5):303-10
pubmed: 19907806
Molecules. 2017 Jul 25;22(8):
pubmed: 28757554
J Agric Food Chem. 2007 Dec 26;55(26):10635-40
pubmed: 18038998
Org Biomol Chem. 2011 Aug 21;9(16):5670-81
pubmed: 21706121
Curr Pharm Biotechnol. 2018;19(13):1019-1048
pubmed: 30417783